OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
Tommaso Lorenzo Parigi, Ferdinando D’Amico, María T. Abreu, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 9, pp. 853-859
Closed Access | Times Cited: 43

Showing 26-50 of 43 citing articles:

Physical activity in the prevention and management of inflammatory bowel disease: a systematic review
Carmela Protano, Francesca Gallè, Veronica Volpini, et al.
Journal of Public Health (2024)
Open Access | Times Cited: 3

Development and Validation of a Mobile-Centered Digital Health Readiness Scale (mDiHERS): Health Literacy and Equity Scale
Hana Kim, Rebecca Schnall, Nagyeom Yoon, et al.
Journal of Medical Internet Research (2024) Vol. 26, pp. e58497-e58497
Open Access | Times Cited: 3

Phyllanthus emblica L. polysaccharides ameliorate colitis via microbiota modulation and dual inhibition of the RAGE/NF-κB and MAPKs signaling pathways in rats
Yingying Chen, Sheng-Yi Chen, Hsin‐Yu Chang, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 129043-129043
Closed Access | Times Cited: 9

Artificial intelligence-enabled advanced endoscopic imaging to assess deep healing in inflammatory bowel disease
Yasuharu Maeda, Ilaria Ditonno, Miguel Puga‐Tejada, et al.
eGastroenterology (2024) Vol. 2, Iss. 3, pp. e100090-e100090
Open Access | Times Cited: 2

Upadacitinib in patients with difficult-to treat Crohn’s disease
Cristina Bezzio, Gianluca Franchellucci, Edoardo Savarino, et al.
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 2

Protective effect of 5,4'-dihydroxy-6,8-dimethoxy7-O-rhamnosylflavone from Indigofera aspalathoides Vahl on lipopolysaccharide-induced intestinal injury in mice
Abdullah M. Alzahrani, Peramaiyan Rajendran, Gamal M. Bekhet, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3537-3551
Closed Access | Times Cited: 2

Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease
Tommaso Lorenzo Parigi, Luca Massimino, Alfredo Carini, et al.
Journal of Crohn s and Colitis (2024)
Closed Access | Times Cited: 2

The Management of Postoperative Recurrence in Crohn’s Disease
Ernesto Fasulo, Ferdinando D’Amico, Laura Osorio, et al.
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 119-119
Open Access | Times Cited: 4

Terápiás kihívások nehezen kezelhető, penetráló Crohn-betegségben – multidiszciplináris megoldás
B Farkas, Péter Bacsúr, Emese Ivány, et al.
Orvosi Hetilap (2024) Vol. 165, Iss. 32, pp. 1252-1257
Open Access | Times Cited: 1

Translational characterization of immune pathways in inflammatory bowel disease: insights for targeted treatments
Sabrina Nicolò, Ilaria Faggiani, C Errico, et al.
Expert Review of Clinical Immunology (2024), pp. 1-18
Closed Access | Times Cited: 1

Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019
Zhili Dou, Huiling Zheng, Yanyan Shi, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 11, pp. 103655-103655
Closed Access | Times Cited: 1

Dual Biologic Therapy for Refractory Crohn's Disease With Perforation in a Patient Declining Surgical Intervention
Puo‐Hsien Le, Chien‐Ming Chen, Chia‐Jung Kuo, et al.
ACG Case Reports Journal (2023) Vol. 10, Iss. 11, pp. e01203-e01203
Open Access | Times Cited: 2

Risk Factors and Postoperative Outcomes in Pouchitis Following Restorative Proctocolectomy: An 18-Year Single-Center Study
Luisa Bertin, M. M. Nasrallah, Carlo Redavid, et al.
Gastroenterology Insights (2024) Vol. 15, Iss. 4, pp. 1075-1092
Open Access

Identification of Disulfidptosis-Related Genes in Ulcerative Colitis
Yuan Liu, Lin Lü, Jing Lu, et al.
(2024)
Closed Access

Zein: Potential biopolymer in inflammatory bowel diseases
Nimeet Desai, Smit Nayi, Dignesh Khunt, et al.
Journal of Biomedical Materials Research Part A (2024)
Closed Access

Delivery of Encapsulated Intelligent Engineered Probiotic for Inflammatory Bowel Disease Therapy
Zhen‐Ping Zou, Zhihao Cai, Xiao Peng Zhang, et al.
Advanced Healthcare Materials (2024)
Closed Access

Editorial: If STRIDE‐II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails—Authors' reply
Axel Dignaß, Stefan Rath, Thomas Kleindienst, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 6, pp. 634-635
Open Access

Vancomycin in the treatment of Inflammatory Bowel Disease: There is a role beyond Clostridioides difficile infection.
Paula Calderón, Oriana M. Damas, Paulina Núñez, et al.
Revista Española de Enfermedades Digestivas (2023)
Open Access

Current Management of Pouchitis
Bo Shen
Current Treatment Options in Gastroenterology (2023) Vol. 21, Iss. 4, pp. 395-410
Closed Access

Previous Page - Page 2

Scroll to top